Aliases & Classifications for Facial Paralysis

About this section

Aliases & Descriptions for Facial Paralysis:

Name: Facial Paralysis 10 12 36 65
Facial Palsy 10
 
Bell Palsy 65

Classifications:



External Ids:

Disease Ontology10 DOID:13934
ICD1027 G51.0
MeSH36 D005158
NCIt42 C26769
UMLS65 C0015469

Summaries for Facial Paralysis

About this section
MalaCards based summary: Facial Paralysis, also known as facial palsy, is related to secondary syphilis and facial hemiatrophy, and has symptoms including sleeplessness, generalized muscle weakness and unilateral facial paresis. An important gene associated with Facial Paralysis is TGFB1 (Transforming Growth Factor Beta 1), and among its related pathways are Cytokines and Inflammatory Response and IL12 signaling mediated by STAT4. The drugs scopolamine and scopolamine hydrobromide have been mentioned in the context of this disorder. Affiliated tissues include bone, breast and prostate, and related mouse phenotypes are integument and respiratory system.

Related Diseases for Facial Paralysis

About this section

Diseases related to Facial Paralysis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 174)
idRelated DiseaseScoreTop Affiliating Genes
1secondary syphilis30.1CD4, CD40LG
2facial hemiatrophy24.3ANKH, CADM1, CD4, CD40LG, GSN, HOXA2
3familial recurrent peripheral facial palsy12.1
4recurrent peripheral facial palsy12.1
5congenital hereditary facial paralysis with variable hearing loss12.0
6isolated hereditary congenital facial paralysis12.0
7anotia facial palsy cardiac defect11.9
8deafness conductive stapedial ear malformation facial palsy11.9
9deafness-ear malformation-facial palsy syndrome11.9
10bell's palsy11.7
11toxic diffuse goiter10.7CD40LG, TGFB1
12thymus lymphoma10.7CADM1, LIPN
13severe nonproliferative diabetic retinopathy10.6GSN, TGFB1
14locked-in syndrome10.5NF2, TGFB1
15moebius syndrome10.5
16oral cavity cancer10.5CD4, CD40LG
17ichthyosis with confetti10.5LRP5, TGFB1
18hymenolepiasis10.5CD4, CD40LG
19sacral spinal canal and spinal cord meningioma10.5CD4, CD40LG
20ocular hypotension10.5CD4, CD40LG
21hereditary night blindness10.5CD4, CD40LG
22coronin-1a deficiency10.5CD4, CD40LG
23nelson syndrome10.5LIPN, LRP5
24differentiating neuroblastoma10.5CD4, CD40LG
25plasma protein metabolism disease10.5CD4, CD40LG
26calcific tendinitis10.5CD4, CD40LG
27microsporidiosis10.5CD4, CD40LG
28late congenital syphilis10.5CD4, CD40LG
29scleritis10.5CD4, CD40LG
30lacrimal duct obstruction10.5CD4, CD40LG
31melkersson-rosenthal syndrome10.5
32pityriasis rosea10.5CD4, CD40LG
33cd40 deficiency10.5CD4, CD40LG
34louping ill10.5CD4, CD40LG
35inflammatory leiomyosarcoma10.5CD4, CD40LG
36nodular episcleritis10.5LIPN, LRP5
37mobitz type ii atrioventricular block10.5CD4, CD40LG
38juvenile spinal muscular atrophy10.5CD4, CD40LG
39hyperinsulinism10.4CD4, CD40LG
40paralytic squint10.4CD4, CD40LG
41pharyngoconjunctival fever10.4CD4, CD40LG
42tuberculous epididymitis10.4CD40LG, HOXB1, LIPN
43vein disease10.4CD4, CD40LG
44learning disability10.4CD4, CD40LG
45arcus senilis10.4CD4, CD40LG
46autoimmune disease of cardiovascular system10.4CD4, CD40LG
47b cell deficiency10.4CD4, CD40LG
48aniseikonia10.4CD4, CD40LG
49peripheral artery disease10.4CD4, CD40LG
50cystic echinococcosis10.4CD4, TGFB1

Comorbidity relations with Facial Paralysis via Phenotypic Disease Network (PDN):


Acute CystitisAphasia
Exposure KeratitisHypertension, Essential
Ischemic Heart DiseaseMechanical Ectropion
Paralytic LagophthalmosSwallowing Disorders
Transient Cerebral IschemiaGeniculate Herpes Zoster
Parotid Gland Cancer

Graphical network of the top 20 diseases related to Facial Paralysis:



Diseases related to facial paralysis

Symptoms for Facial Paralysis

About this section

UMLS symptoms related to Facial Paralysis:


sleeplessness, generalized muscle weakness, unilateral facial paresis, diaphragmatic paresis, vertigo/dizziness, facial paresis, muscle weakness, chronic pain, tremor, syncope, seizures, sciatica, pain, oral manifestations, flaccid muscle tone, headache, back pain, hemifacial paralysis, facial palsy, lower motor neuron, facial palsy, upper motor neuron, ophthalmoplegia, hemiplegia

Drugs & Therapeutics for Facial Paralysis

About this section

Drugs for Facial Paralysis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 67)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
PrednisoloneapprovedPhase 4, Phase 3108250-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
Flo-pred
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
MLS001304083
 
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
Millipred
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Omnipred
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
2
MethylprednisoloneapprovedPhase 4, Phase 3108283-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
A-methapred
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Depo-medrol
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Solu-medrol
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
3
LidocaineapprovedPhase 41103137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Afterburn
Akten
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bikini Zone Medicated
Bikini Zone Medicated Creme
Bio-0767
Bio-scriptives Lidum
Bio-scriptives Lidum Hemorroidal (anorectal)
Bio-scriptives Lidum Topical Analgesic
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
Burn Relief Leader
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Comfortcaine
Cuivasil
Curacaine Transdermal Corporation
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
Derma Numb
DermaFlex
Desert Harvest Releveum
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Dr. Numb
Dr. Richs Numbing
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gigi Anesthetic Numbing
Gravocain
H-releve Hemorrhoidal
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
Hawaiian Tropic
Hush Anesthetic
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
LS-805
Lanabiotic
 
Laryng-o-jet
Leostesin
Lida-Mantle
Lidall
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine 4% Cream
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Hydrochloride
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocaine hydrochloride
Lidocainum
Lidocainum [INN-Latin]
Lidocare Mist
Lidocaton
Lidocream 4
Lidocream 5
Lidoderm
Lidoderm 5
Lidoject-1
Lidoject-2
Lifestyles Epic Male Genital Desensitizer
Lignocaine
Lignocainum
Lingocaine
Lmx4
Lmx5
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Numb Master Topical Anesthetic
Numb Nuts
Ocean Potion Instant Burn Relief Ice
Octocaine
Octocaine-100
Octocaine-50
Plum Smooth Plumb Numb Gelee
Premjact Male Desensitizer Pound International
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Recticare
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Simplicity Desensitizing
Simply Numb Endure
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Sole Serum
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Walgreens Aloe Vera Pain Relieving
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocaine-mpf
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zcaine Fast Acting Anesthetic
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
4Prednisolone phosphatePhase 4, Phase 31082
5Prednisolone hemisuccinatePhase 4, Phase 31082
6Protective AgentsPhase 4, Phase 35651
7Prednisolone acetatePhase 4, Phase 31082
8VaccinesPhase 4, Phase 36085
9OnabotulinumtoxinAPhase 4, Phase 2588
10AcyclovirPhase 4153
11IncobotulinumtoxinAPhase 4, Phase 2599
12Botulinum Toxins, Type APhase 4, Phase 2588
13AbobotulinumtoxinAPhase 4, Phase 2588
14valacyclovirPhase 4101
15Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 218510
16Antineoplastic Agents, HormonalPhase 4, Phase 34256
17Antiviral AgentsPhase 48071
18Anti-Inflammatory AgentsPhase 4, Phase 38478
19Anti-Infective AgentsPhase 417220
20AntiemeticsPhase 4, Phase 33213
21Neuroprotective AgentsPhase 4, Phase 31376
22Gastrointestinal AgentsPhase 4, Phase 36401
23glucocorticoidsPhase 4, Phase 33896
24Methylprednisolone HemisuccinatePhase 4, Phase 31082
25Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 39988
26Methylprednisolone acetatePhase 4, Phase 31082
27Hormone AntagonistsPhase 4, Phase 310002
28HormonesPhase 4, Phase 311748
29Central Nervous System DepressantsPhase 410016
30Anesthetics, LocalPhase 42347
31AnestheticsPhase 47385
32Sodium Channel BlockersPhase 41180
33Diuretics, Potassium SparingPhase 41445
34Anti-Arrhythmia AgentsPhase 42371
35
TenecteplaseapprovedPhase 3, Phase 239191588-94-0
Synonyms:
191588-94-0
D06070
Tenecteplase
Tenecteplase (USAN/INN)
 
Tissue-type plasminogen activator precursor
Tnkase
Tnkase (TN)
t- PA
t-plasminogen activator
tPA
36
AspirinapprovedPhase 3102950-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
7 Select Adult Chewable Aspirin
7 Select Aspirin
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Adult Chewable Low Dose Aspirin
Adult Low Dose Aspirin
Adult Low Dose Aspirin Enteric Safety Coated
Adult Low Dose Enteric Coated Aspirin
Adult Low Strength Aspirin
Aloxiprimum
Asacard
Asagran
Asaphen
Asatard
Ascoden-30
Ascriptin Maximum Strength Buffered Aspirin
Ascriptin Regular Strength Buffered Aspirin
Aspalon
Aspec
Aspergum
Aspi-cor
Aspir Low
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin 81 Mg
Aspirin 81 Mg Low Dose
Aspirin Adult Low Dose
Aspirin Adult Low Strength
Aspirin Adult Low Strength Aspirin
Aspirin Adult low strength
Aspirin Chewable Low Dose
Aspirin Delayed Release
Aspirin EC
Aspirin EXTRA STRENGTH
Aspirin Ec
Aspirin Enteric
Aspirin Enteric Coated
Aspirin Enteric Coated Low Dose
Aspirin Enteric Safety Coated
Aspirin Enteric Safety-Coated
Aspirin Low Dose
Aspirin Low Dose Chewable
Aspirin Low Dose Enteric Coated
Aspirin Low Dose Safety Coated
Aspirin Low Strength
Aspirin Nsaid
Aspirin Regular Strength
Aspirin Regular Strength regular strength
Aspirin Regular strength
Aspirin Safety Coated
Aspirin Safety Coated Adult Low Dose
Aspirin Safety coated
Aspirin Thin coated
Aspirin [BAN:JAN]
Aspirin adult low dose
Aspirin adult low strength
Aspirin enteric safety coated
Aspirin low dose
Aspirin low dose chewable
Aspirin low dose enteric coated
Aspirin regular strength
Aspirina 03
Aspirine
Aspiring
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Advanced Aspirin Extra Strength
Bayer Advanced Aspirin Regular Strength
Bayer Aspirin 8 Hour
Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange
Bayer Aspirin Regimen Regular Strength
Bayer Buffered
Bayer Chewable - Aspirin Regimen Low Dose Aspirin Cherry Flavored
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Fast Release
Bayer Genuine Aspirin
Bayer Low Dose
Bayer Plus
Bayer Plus Extra Strength
Bayer Womens
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Buffered Aspirin
Bufferin
Bufferin LOW DOSE BUFFERED ASPIRIN
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Care One Aspirin
Cemirit
Chewable Adult Low Dose Aspirin
Chewable Aspirin
Chewable Low Dose Aspirin
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Critical Care Aspirin To Go
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dg Health Aspirin
Direct Safety Aspirin
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ec-81aspirin Enteric Coated
Ecolen
Ecotrin
Ecotrin Regular Strength
Empirin
Empirin with Codeine
Endosprin
Endydol
Enteric Aspirin
Enteric Coated Aspirin
Enteric Coated Aspirin Regular Strength
Enteric Coated Aspirin Regular strength
Enteric Coated Aspirin regular strength
Enteric Coated Asprin 81 Mg
Enteric Coated Low Dose Aspirin
 
Enteric Safety Coated Aspirin
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Equaline Aspirin
Equaline Aspirin adult low dose
Equate Aspirin
Equate Aspirin chewable
Extren
Fasprin
Flanax Aspirin Pain Reliever
Formucare Aspirin
Genuine Aspirin
Globentyl
Globoid
Good Neighbor Pharmacy Aspirin
Good Neighbor Pharmacy Aspirin Enteric Safety Coated
Good Neighbor Pharmacy Aspirin orange flavor chewable
Good Sense Aspirin
Good Sense Aspirin Enteric Safety Coated
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Handy Solutions Genuine Aspirin Bayer
Health Mart Aspirin
Health Mart Regular Strength Enteric Coated Aspirin
Health Sense Adult Chewable Low Strength Aspirin
Health Sense Aspirin 81
Health Sense Ecpirin
Healthy Accents Aspirin
Helicon
Henry Schein Aspirin
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kroger Value Aspirin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Leader Aspirin
Leader Cardinal Health Aspirin
Leader Low Dose Aspirin
Levius
Lopac-A-5376
Lopac0_000038
Low Dose Adult Aspirin
Low Dose Aspirin
Low Dose Aspirin 81 Mg Safety Coated
Low Dose Aspirin Enteric Safety Coated
Low Dose Asprin
Low Dose Chewable Aspirin
Low Dose Miniprin Enteric Safety Coated
Low Dose Pain Relief Aspirin
Low Strength Chewable Aspirin
Low-dose Aspirin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medi First Plus Aspirin
Medi-first Aspirin
Medique Aspirin
Medisyl
Micristin
Micro-coated Aspirin
Miniprin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
North Aspirin
Novasen
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Pain Relief Aspirin
Pain Relief Aspirin Low Dose
Persistin
Pharbest Aspirin 325mg
Pharbest Regular Strength Aspirin
Pharmacin
Pirseal
Plus Pharma NSAID 325 mg
Plus Pharma Nsaid Aspirin
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rapid Comfort Aspirin
Regular Strength Aspirin
Regular Strength Aspirin Ec
Regular Strength Buffered Aspirin
Regular Strength Enteric Aspirin
Regular Strength Enteric Coated Aspirin
Regular Strength Pain Relief
Regular Strength Tri-buffered Aspirin
Rexall Aspirin
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
Rugby Aspirin
Rx Act Aspirin
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Safety Coated Aspirin
Safety Coated Enteric Aspirin
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Smart Health Aspirin regular strength
Smart Sense Aspirin
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Solves - Aspirin Cherry
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
St. Joseph Chewable Aspirin
St. Joseph Safety Coated Aspirin
Sunmark Aspirin
Sunmark Aspirin Regular Strength
Sunmark Aspirin adult low strength
Sunmark Aspirin low dose
Supac
Tasprin
Temperal
Toldex
Topcare Aspirin
Tri-buffered Aspirin
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Uncoated Aspirin
Value Pharma Aspirin Pain Reliever
Value Pharmapain Reliever Extra Strength
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
Zee Aspirin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
37
Clopidogrelapproved, nutraceuticalPhase 3717120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel Bisulfate
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
 
IDI1_000787
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
38Fibrinolytic AgentsPhase 3, Phase 21567
39Neurotransmitter AgentsPhase 3, Phase 2, Phase 114795
40Immunologic FactorsPhase 318483
41Purinergic P2Y Receptor AntagonistsPhase 3654
42Tissue Plasminogen ActivatorPhase 3202
43PlasminogenPhase 3198
44Purinergic P2 Receptor AntagonistsPhase 3656
45Plasminogen InactivatorsPhase 310
46Platelet Aggregation InhibitorsPhase 31935
47
AcetylcholineexperimentalPhase 268951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
48Cholinergic AgentsPhase 23243
49Neuromuscular AgentsPhase 2922
50Botulinum ToxinsPhase 2616

Interventional clinical trials:

(show top 50)    (show all 55)
idNameStatusNCT IDPhase
1Scandinavian Bell's Palsy StudyCompletedNCT00510263Phase 4
2Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of AgeCompletedNCT01985997Phase 4
3Post Marketing Surveillance Study of DysportCompletedNCT00210431Phase 4
4Reinnervation of Facial Muscles After Lengthening Temporalis MyoplastyTerminatedNCT01833221Phase 4
5Corticosteroids in Prevention of Facial Palsy After Cranial Base SurgeryCompletedNCT00438087Phase 3
6Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801CompletedNCT01604746Phase 3
7Quadrant Versus Superficial ParotidectomyRecruitingNCT01607866Phase 2, Phase 3
8A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven OcclusionRecruitingNCT02398656Phase 3
9Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled StudyWithdrawnNCT01614977Phase 3
10Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown LinesCompletedNCT00430586Phase 2
11TNK-tPA Evaluation for Minor Ischemic Stroke With Proven OcclusionCompletedNCT01654445Phase 2
12Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)Not yet recruitingNCT02728778Phase 2
13Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial SyndromeTerminatedNCT01127503Phase 2
14Study of Inhaling Carbon Monoxide to Treat Patients With Intestinal Paralysis After Colon Surgery.TerminatedNCT01050712Phase 2
15Safety Study of Inhaling Carbon Monoxide in Healthy VolunteersTerminatedNCT01050933Phase 1
16Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial ParalysisCompletedNCT00903669
17Randomized Controlled Trial of Acupuncture to Treat Bell's Palsy According to Different StagesCompletedNCT00608660
18Myofunctional Therapy in Facial PalsyCompletedNCT00989209
19Study of a New Technique to Improve the Symptoms of Orofacial Discomfort in Patients With Peripheral Facial ParalysisCompletedNCT01327157
20Microbiologic Findings of Acute Facial Palsy in ChildrenCompletedNCT01537952
21Steroid-Antiviral Treatment in Rehabilitation of Facial PalsyCompletedNCT02328079
22A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's PalsyCompletedNCT01686464
23Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s PalsyCompletedNCT00561106
24Acupuncture With Deqi And Psychological Effects in Treatment of Bell's PalsyCompletedNCT00685789
25Cognitive Function and Emotional Possessing in Bilateral Facial PalsyCompletedNCT02179450
26Complications in Parotid SurgeryCompletedNCT02486393
27Retrospective Clinical Outcome of Parotid Tumor SurgeryCompletedNCT01983176
28Ultrasound Evaluation of Tongue Movements in Speech and SwallowingCompletedNCT00001167
29Clinical Research Core Dental Screening ProtocolCompletedNCT00090818
30Cognitive Remediation in 22q11DSCompletedNCT01781923
31MDs on Botox Utility (MOBILITY)CompletedNCT00535938
32Brain Reorganization Following Constraint-Induced Therapy in Children With Cerebral PalsyCompletedNCT00100503
33Natural History in CCFDN and IBM SyndromesCompletedNCT01902940
34Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)CompletedNCT01274611
35Home-Based Diagnosis and Management of Sleep-Related Breathing Disorders in Spinal Cord InjuryCompletedNCT01882257
36Tactile Learning in Stroke PatientsCompletedNCT00283881
37The Relationship Between Psychological Factors and Bell's PalsyRecruitingNCT01377766
38The Role of a Device to Evaluate the Neuromuscular Function in Assessing Muscle in Facial Paralysis PatientsRecruitingNCT02489162
39Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in ChinaRecruitingNCT01201642
40Post-parotidectomy Facial Paresis: Intraoperative and Postoperative FactorsRecruitingNCT02527226
41Quantification, Analysis and Simulation of Facial Mimics MovementsRecruitingNCT02002572
42R. I. S. POS. T. ARecruitingNCT01991665
43A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme DiseaseRecruitingNCT02741609
44Popliteal Block for Postoperative Pain in Knee-ankle Soft Tissue Surgery in Cerebral PalsyRecruitingNCT02507700
45Effect of DBS on Quality of Life in Dyskinetic Cerebral PalsyRecruitingNCT02097693
46Effects of Altering Handle Height of Posterior WalkersRecruitingNCT02467829
470205 Esteem New Subject Enrollment Post Approval StudyRecruitingNCT02689349
48Human Movement DatabaseRecruitingNCT00001252
49ePrime: Evaluation of Magnetic Resonance (MR) Imaging to Predict Neurodevelopmental Impairment in Preterm InfantsActive, not recruitingNCT01049594
50Surgery or Clincial Follow up, in Patients With Bell' s PalsyEnrolling by invitationNCT02179684

Search NIH Clinical Center for Facial Paralysis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: facial paralysis

Genetic Tests for Facial Paralysis

About this section

Anatomical Context for Facial Paralysis

About this section

MalaCards organs/tissues related to Facial Paralysis:

33
Bone, Breast, Prostate, Brain, Thyroid, Lung, Heart

Animal Models for Facial Paralysis or affiliated genes

About this section

MGI Mouse Phenotypes related to Facial Paralysis:

38 (show all 14)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.6CD4, CD40LG, GSN, HOXB1, NF2, TGFB1
2MP:00053888.4ANKH, GSN, HOXA2, HOXB1, NF2, TGFB1
3MP:00053828.2ANKH, HOXA2, HOXB1, LRP5, NF2, TGFB1
4MP:00028738.0CADM1, CD4, HOXA2, HOXB1, LRP5, MBP
5MP:00053778.0ANKH, HOXA2, HOXB1, MBP, NF2
6MP:00053797.7CADM1, CD4, CD40LG, GSN, HOXB1, LRP5
7MP:00053897.6ANKH, CADM1, CD40LG, GSN, MBP, NF2
8MP:00053787.2ANKH, CADM1, CD4, HOXA2, HOXB1, LRP5
9MP:00053906.9ANKH, CADM1, CD40LG, GSN, HOXA2, HOXB1
10MP:00036316.4CADM1, CD4, CD40LG, GSN, HOXA2, HOXB1
11MP:00053846.2ANKH, CADM1, CD4, CD40LG, GSN, HOXA2
12MP:00107686.0ANKH, CD4, CD40LG, GSN, HOXA2, HOXB1
13MP:00053976.0ANKH, CADM1, CD4, CD40LG, GSN, HOXB1
14MP:00053875.8ANKH, CADM1, CD4, CD40LG, GSN, HOXB1

Publications for Facial Paralysis

About this section

Articles related to Facial Paralysis:

(show top 50)    (show all 601)
idTitleAuthorsYear
1
Reply: Epidemiological overview of synkinesis in 353 patients with longstanding facial paralysis under treatment with botulinum toxin for 11 years. (27088841)
2016
2
Antiviral treatment for Bell's palsy (idiopathic facial paralysis). (26559436)
2015
3
Recurrent facial paralysis for 12 years. (26448255)
2015
4
One-stage dual latissimus dorsi muscle flap transfer with a pair of vascular anastomoses and double nerve suturing for long-standing facial paralysis. (25819029)
2015
5
Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer. (25868011)
2015
6
Recycle of temporal muscle in combination with free muscle transfer in the treatment of facial paralysis. (23283482)
2013
7
State of the art in treatment of facial paralysis with temporalis tendon transfer. (23842289)
2013
8
Facial paralysis and mediastinitis due to odontogenic infection and poor prognosis. (24220381)
2013
9
Use of an individual mandibular advancement device for an?obstructive sleep apnoea patient with facial paralysis: a short-term follow-up case report. (22329406)
2012
10
Facial paralysis and lymphocytic facial neuritis in a rhesus macaque (Macaca mulatta) positive for simian retrovirus type D2. (22330582)
2011
11
Peripheral facial paralysis and bilateral carotid pseudoaneurysms of petrous localization: a case report. (23984216)
2011
12
Dynamic facial prosthetics for sufferers of facial paralysis. (23386867)
2011
13
Management and outcomes of facial paralysis from intratemporal blunt trauma: a systematic review. (21225812)
2010
14
Effect of delayed decompression after early steroid treatment on facial function of patients with facial paralysis. (19437165)
2010
15
Sir Charles Bell was not affected by facial paralysis himself! (20464311)
2010
16
Secondary surgery in paediatric facial paralysis reanimation. (20018580)
2010
17
Bilateral otitis media with facial paralysis in a Japanese black calf. (19684349)
2009
18
Outcomes of direct muscle neurotization in pediatric patients with facial paralysis. (20009835)
2009
19
Secondary surgery in adult facial paralysis reanimation. (19952647)
2009
20
Facial paralysis: research and future directions. (18470838)
2008
21
Combination of hypoglossal-facial nerve jump graft by end-to-side neurorrhaphy and cross-face nerve graft for the treatment of facial paralysis. (17530609)
2007
22
Correction of ectropion in facial paralysis. (16462363)
2006
23
A comparison of commissure excursion following gracilis muscle transplantation for facial paralysis using a cross-face nerve graft versus the motor nerve to the masseter nerve. (16772949)
2006
24
Neurovascularized free short head of the biceps femoris muscle transfer for one-stage reanimation of facial paralysis. (15692342)
2005
25
Anthropometric measurements of the endoscopic eyebrow lift in the treatment of facial paralysis. (12794455)
2003
26
Facial paralysis in Wegener's granulomatosis of the middle ear. (11276335)
2001
27
Impact of facial paralysis on patients with acoustic neuroma. (10983957)
2000
28
Reanimation of early facial paralysis with hypoglossal/facial end-to-side neurorrhaphy: a new approach. (10954315)
2000
29
The SOOF lift as an adjunct in rehabilitation of facial paralysis: help or hype? (11460300)
2000
30
Primary facial rehabilitation in facial paralysis after extirpative surgery. (11074718)
2000
31
The effect of muscle transplantation after unilateral partial facial paralysis on craniofacial growth and development: relationship between muscle and nerve histomorphometric findings. (10626980)
2000
32
Surgical management of the facial nerve in craniofacial trauma and long-standing facial paralysis: cadaver study and clinical presentations. (11951222)
1999
33
Temporal bone hemangioma as a cause of facial paralysis. (10089691)
1999
34
Necrotizing otitis externa, otitis media, peripheral facial paralysis, and brain abscess in a thalassemic child after allogeneic BMT. (9783316)
1998
35
Evaluating facial paralysis. Expensive diagnostic tests are often unnecessary. (9633550)
1998
36
Neurovascular free muscle transfer combined with cross-face nerve grafting for the treatment of facial paralysis in children. (9623816)
1998
37
Iatrogenic facial paralysis prevention. (8972995)
1996
38
Surgical facial nerve decompression for peripheral facial paralysis of diverse causes. (8828273)
1996
39
Symmetry and synkinesis during rehabilitation of unilateral facial paralysis. (7674438)
1995
40
Early temporalis muscle transposition for the management of facial paralysis. (7666737)
1995
41
Facial paralysis in children. (8572104)
1994
42
Long-term follow-up of nerve conduction velocity in cross-face nerve grafting for the treatment of facial paralysis. (8171133)
1994
43
Long-term results of severe facial paralysis. (10774436)
1994
44
Anti-Borrelia burgdorferi antibodies in sera of patients with facial paralysis. (10774421)
1994
45
Comments regarding prognostic significance of stapes reflex in Bell's palsy, application of electroneuronography in managing Bell's palsy, and tuberculosis of the middle ear in facial paralysis, management of an injured facial nerve following middle ear surgery. (1805644)
1991
46
Syndrome of anotia, facial paralysis, and congenital heart disease. (6470867)
1984
47
PAROTITIS AND FACIAL PARALYSIS IN MID-LINE GRANULOMA. (14256342)
1965
48
Superior petrosal and cavernous sinus thrombosis and basal petrositis; observed as complication of destructive labyrinthitis with facial paralysis. (20284480)
1947
49
The Association of Optic Neuritis, Facial Paralysis, and Facial Hemiatrophy. (16693016)
1934
50

Variations for Facial Paralysis

About this section

Expression for genes affiliated with Facial Paralysis

About this section
Search GEO for disease gene expression data for Facial Paralysis.

Pathways for genes affiliated with Facial Paralysis

About this section

Pathways related to Facial Paralysis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.7CD4, TGFB1
29.7CD4, TGFB1
39.7CD4, CD40LG
49.5GSN, LRP5
59.3CADM1, CD4, CD40LG

GO Terms for genes affiliated with Facial Paralysis

About this section

Biological processes related to Facial Paralysis according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1lens fiber cell differentiationGO:007030610.3NF2, TGFB1
2negative regulation of DNA replicationGO:000815610.3NF2, TGFB1
3negative regulation of cell-cell adhesionGO:002240810.3NF2, TGFB1
4pattern specification processGO:000738910.1HOXA2, HOXB1
5oligodendrocyte developmentGO:001400310.0GSN, TGFB1
6T cell costimulationGO:00312959.8CD4, CD40LG
7response to progesteroneGO:00325709.7MBP, TGFB1
8T cell activationGO:00421109.7CD4, TGFB1
9anterior/posterior pattern specificationGO:00099529.6HOXA2, HOXB1, LRP5
10myelinationGO:00425529.4MBP, TGFB1
11response to vitamin DGO:00332809.4CD4, TGFB1

Sources for Facial Paralysis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet